Biopharmaceutical company Gilead Sciences (NASDAQ:GILD) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 1 ...

Discover how Offred survives Gilead’s tyranny in The Handmaid’s Tale through silence, memory, and quiet rebellion, proving ...

The approval recommendation for lenacapavir is supported by solid Phase 3 data from the PURPOSE 1 and 2 studies. PURPOSE 1 ...

Here is a capsule look at the 2025 Marion-area high school boys and girls golf teams. Cardington, Mount Gilead and Northmor's boys teams did not repsond to repeated information requests. Conference: ...

On August 11, Sensex closed 746.29 points or 0.93 percent higher at 80,604.08, and the Nifty ended 221.75 points or 0.91 ...

JPMorgan (NYSE: JPM) told investors in a note Monday that Eli Lilly & Co. (NYSE: LLY) shares are its “top pick” among U.S.

Kymera Therapeutics' Q2 2025 earnings call highlights clinical progress, Gilead and Sanofi partnerships, and financial strength, setting a strong stage ...

A Menlo Park medical device startup is breathing new life into the fight against severe emphysema with a groundbreaking ...

Gift Nifty was trading 24,447 around level, a premium of nearly 6 points from the Nifty futures’ previous close, indicating a ...

U.S. stocks are drifting near their record heights as Wall Street waits for an upcoming update on inflation.

Instead of confronting the structural forces that create and sustain homelessness, these strategies shift responsibility onto ...